Brentwood, Tenn.-based ASC chain Surgery Partners recorded $776 million in revenue during the first quarter of 2025, an increase of 8.2% compared to the first quarter of 2024.
Here are nine more notes, according to a May 12 news release from the company.
- In the first quarter of 2025, same-facility revenues increased 5.2% compared to the first quarter of 2024.
- Same-facility cases increased 6.5% in the first quarter of 2025 compared to the same period of 2024.
- The company recorded a 1.2% decrease in revenue per case during the first quarter of 2025.
- Surgery Partners had an EBITDA of $103.9 million during the first quarter of 2025, up from $97.5 million in the first quarter of 2024.
- The company had a net loss of $37.7 million in the quarter.
- Full year 2025 revenue for the company is expected to be between $3.3 billion and $3.45 billion.
- Under its revolving credit facility, Surgery Partners has nearly $400 million of borrowing capacity.
- Surgery Partners had $229.3 million of cash and cash equivalents as of March 31, 2025.
- The company’s ratio of total debt to EBITDA was about 4.1x at the end of 2025’s first quarter.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.